XRAY
DENTSPLY SIRONA Inc.
$12.61
+$0.02(+0.16%)
48
Overall
80
Value
27
Tech
39
Quality
Market Cap
$2.61B
Volume
2.90M
52W Range
$11.69 - $24.86
Target Price
$15.88
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $2.7B | $3.7B | $4.0B | $4.0B | $4.1B | $3.3B | $4.2B | $3.9B | $4.0B | $3.8B | ||
| Total Revenue | $2.7B | $3.7B | $4.0B | $4.0B | $4.0B | $3.3B | $4.2B | $3.9B | $4.0B | $3.8B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $1.2B | $1.7B | $1.8B | $1.9B | $1.9B | $1.7B | $1.9B | $1.8B | $1.9B | $1.8B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $1.5B | $2.0B | $2.2B | $2.1B | $2.2B | $1.7B | $2.3B | $2.1B | $2.1B | $2.0B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $1.1B | $1.5B | $1.7B | $1.7B | $1.8B | $1.4B | $1.7B | $1.8B | $1.8B | $1.8B | ||
| Research & Development | $-74.9M | $-128.5M | $-151.7M | $-160.5M | $131.0M | $123.0M | $171.0M | $174.0M | $184.0M | $165.0M | ||
| Research Expense | -- | -- | -- | -- | $131.0M | $123.0M | $171.0M | $174.0M | $184.0M | $165.0M | ||
| Selling, General & Administrative | $1.1B | $1.5B | $1.7B | $1.7B | $1.7B | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B | ||
| Selling & Marketing Expenses | $1.1B | $1.5B | $1.7B | $1.7B | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-30.4M | $-33.3M | $-28.3M | $-38.7M | $1.7B | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B | ||
| Salaries & Wages | $-24.3M | $-39.7M | $-46.6M | $-23.0M | $-8.0M | $-5.0M | $-6.0M | -- | -- | -- | ||
| Depreciation & Amortization | $-122.9M | $-271.7M | $-316.4M | $-330.8M | $84.0M | $334.0M | $347.0M | $328.0M | $343.0M | $349.0M | ||
| Depreciation & Amortization | $-122.9M | $-271.7M | $-316.4M | $-330.8M | $84.0M | $334.0M | $347.0M | -- | -- | -- | ||
| Amortization | $-43.8M | $-155.1M | $-189.1M | $-197.9M | $84.0M | $4.0B | $4.0B | $2.7B | $2.4B | $1.6B | ||
| Other Operating Expenses | -- | $-2.2M | $-300.0K | $-11.1M | $-300.0K | $-1.0M | $-16.0M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $439.9M | $477.9M | $-3.5B | $348.7M | $361.0M | $-12.0M | $608.0M | $-937.0M | $-85.0M | $-879.0M | ||
| EBITDA | $519.8M | $753.0M | $-1.2B | $-587.6M | $701.0M | $330.0M | $952.0M | $-662.0M | $249.0M | $-518.0M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $55.9M | $35.9M | $38.3M | $37.3M | $30.0M | $46.0M | $61.0M | $65.0M | $81.0M | $69.0M | ||
| Intinc | $2.2M | $2.0M | $2.4M | $2.1M | $2.0M | $-47.0M | $-55.0M | $-60.0M | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-53.7M | $-33.9M | $-35.9M | $-35.2M | $81.0M | $-47.0M | $-55.0M | $65.0M | $-81.0M | $-69.0M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | $47.0M | -- | -- | -- | -- | ||
| Other Income/Expense | $-6.6M | $-20.1M | $-4.0B | $-34.9M | $-11.0M | $1.0M | $25.0M | $-1.3B | $9.0M | $-12.0M | ||
| Other Special Charges | $8.2M | $20.1M | $4.0B | $34.9M | $12.0M | $-1.0M | $-8.0M | $-53.0M | $-9.0M | $12.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $64.7M | $23.2M | $425.2M | $221.0M | $81.0M | $77.0M | $-159.0M | $14.0M | $67.0M | $53.0M | ||
| Special Income Charges | $-64.7M | $-23.2M | $-2.1B | $-1.3B | $-92.0M | $-234.0M | $159.0M | $-1.3B | $-374.0M | $-1.1B | ||
| Impairment of Capital Assets | $-3.7M | -- | $1.7B | $1.1B | -- | $157.0M | -- | $1.3B | $307.0M | $1.0B | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $385.6M | $476.8M | $-1.6B | $-921.1M | $375.0M | $-4.0M | $606.0M | $-990.0M | $-94.0M | $-867.0M | ||
| Pre-Tax Income | $329.7M | $440.9M | $-1.6B | $-958.4M | $345.0M | $-60.0M | $545.0M | $-1.1B | $-175.0M | $-936.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $77.0M | $9.5M | $-53.2M | $52.5M | $82.0M | $23.0M | $134.0M | $-105.0M | $-43.0M | $-26.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $251.2M | $431.4M | $-1.6B | $-1.0B | $263.0M | $-73.0M | $411.0M | $-950.0M | $-132.0M | $-910.0M | ||
| Net Income (Continuing Operations) | $251.2M | $431.4M | $-1.6B | $-1.0B | $263.0M | $-83.0M | $411.0M | $-950.0M | $-132.0M | $-910.0M | ||
| Net Income (Discontinued Operations) | $251.2M | $431.4M | $-1.6B | $-1.0B | $263.0M | $-73.0M | $411.0M | $-950.0M | $-132.0M | $-910.0M | ||
| Net Income (Common Stockholders) | $251.2M | $429.9M | $-1.6B | $-1.0B | $82.0M | $-73.0M | $411.0M | $-950.0M | $-132.0M | $-910.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $2.2B | $3.3B | $3.5B | $3.6B | $3.7B | $3.1B | $3.6B | $3.6B | $3.7B | $3.6B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $140.0M | $218.0M | $229.4M | $224.3M | $223.1M | $219.2M | $218.4M | $215.5M | $212.0M | $203.2M | ||
| Average Shares Outstanding (Diluted) | $142.5M | $221.6M | $229.4M | $224.3M | $224.4M | $219.2M | $220.2M | $215.5M | $212.0M | $203.2M | ||
| Shares Outstanding | $140.1M | $229.7M | $227.4M | $223.2M | $221.4M | $219.0M | $217.6M | $215.4M | $207.4M | $199.0M | ||
| Basic EPS | $1.79 | $1.97 | $-6.76 | $-4.51 | $1.18 | $-0.38 | $1.93 | $-4.41 | $-0.62 | $-4.48 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $1.18 | $-0.38 | $1.93 | $-4.41 | $-0.62 | $-4.48 | ||
| Diluted EPS | $1.76 | $1.94 | $-6.76 | $-4.51 | $1.17 | $-0.38 | $1.91 | $-4.41 | $-0.62 | $-4.48 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $1.17 | $-0.38 | $1.91 | $-4.41 | $-0.62 | $-4.48 | ||
| Dividend Per Share | $0.29 | $0.31 | $0.35 | $0.35 | $0.38 | -- | $0.43 | $0.52 | $0.56 | $0.64 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | -- | -- | $16.0M | $8.0M | -- | -- | -- | ||
| Earnings from equity interest | $-1.6M | -- | -- | -- | -- | $-1.0M | $-10.0M | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $-1.6M | -- | -- | -- | -- | $-1.0M | $-10.0M | -- | -- | -- | ||
| Fees | -- | -- | -- | -- | $-260.0M | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | -- | $-6.0M | $-1.0M | $14.0M | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | $11.0M | -- | -- | -- | -- | ||
| Minority Interests | $100.0K | $-1.5M | $300.0K | $-100.0K | $5.1B | $5.0B | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | $-9.7M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-30.4M | $-33.3M | $-28.3M | $-38.7M | $1.7B | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B | ||
| Other Impairment Of Capital Assets | $-4.2M | -- | $-346.7M | $-179.2M | $9.0M | $39.0M | $17.0M | $114.0M | -- | -- | ||
| Realized Capital Gain | -- | -- | -- | -- | $5.0M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-30.4M | $-33.3M | $-28.3M | $-38.7M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $1.1B | $1.5B | $1.7B | $1.7B | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | -- | $11.0M | -- | -- | -- | -- | -- | ||
| Restruct | $64.7M | $23.2M | $425.2M | $221.0M | $81.0M | $77.0M | $-159.0M | $14.0M | $67.0M | $53.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XRAY | $12.61 | +0.2% | 2.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |